top of page
ChatGPT Image Dec 3, 2025, 04_00_28 PM_edited.jpg

Neutrophils are central to the future of solid tumor immunotherapy.

Solid tumors create a highly suppressive microenvironment that blocks immune cells and limits the effectiveness of current immunotherapies. Neutrophils, however, naturally home to inflammation and can infiltrate even the most hostile tumor microenvironment.

 

Breakthrough studies now show that specialised anti-tumor neutrophils play a decisive role in tumors control and immunotherapy response:

​

​

Lift's IMAN platform builds on this science by providing a consistent, therapeutically-optimised source of anti-tumor neutrophils capable of infiltrating solid tumors and re-activating anti-tumor immunity in patients who have exhausted standard treatments.

IMANs: Defining the next generation of neutrophil-based cancer therapy.

Cell no background_edited.png

IMANs home naturally to inflamed tumor sites and actively infiltrate the solid tumor microenvironment – reaching niches that are typically inaccessible to other immune cells and cell therapies.

Tumor infiltration

Cell no background_edited.png

IMANs recruit and activate cytotoxic T and NK cells, converting immunologically “cold” tumors into “hot” inflamed environments.

immune 
activation & recruitment

Cell no background_edited.png

IMANs directly kill tumor
cells using innate neutrophil cytotoxic mechanisms, enabling them to target heterogeneous tumors and antigen-escape variants.

Antigen-

independent

tumor killing

Cell no background_edited.png

IMANs are produced using
a scalable, GMP-ready manufacturing process
that supports consistent product quality.

Predictable,

scalable

manufacturing

Cell no background_edited.png

IMANs avoid many of the issues that limit effectiveness of other neutrophil therapies

Maintained
functional
activity

Our platform at a glance.

Screenshot 2025-12-02 at 20.42.37.png

IMAN MoA Video.

IMAN MoA

IMAN MoA

New_Lift Stacked on Dark.png
  • LIFT BioSciences Linked-in

UK Office

Lift Therapeutics
London BioScience Innovation Centre

2 Royal College Street
London

NW1 0NH
United Kingdom

​​​​

Company Reg: 09277638

Ireland Office

Lift Therapeutics

Páirc Na Meán, Spiddal West 

An Spidéal

Co. Galway

H91 CH01

Ireland

US Office
Lift Therapeutics

265 Franklin Street

Suite 1702

Boston, MA 02110

United States of America

Copyright © 2026 Lift Therapeutics. All Rights Reserved.

bottom of page